The patient voice is firmly established as key to determining value in healthcare. This means that pharmaceutical and biotechnology manufacturers should evaluate and evolve how they engage with patients.
This article explores the evolving patient-centric approaches within biopharma market access, enabling you to:
- understand how patients can be involved throughout the product lifecycle
- determine the influence of the patient voice in regulatory and HTA activities
- learn how manufacturers and patients/advocacy groups can work in partnership